Hepatitis Monthly

Published by: Kowsar

A Novel Hydrodynamic Injection Mouse Model of HBV Genotype C for the Study of HBV Biology and the Anti-Viral Activity of Lamivudine

Xiumei Li 1 , Guangze Liu 1 , Meijuan Chen 1 , Yang Yang 1 , Yong Xie 1 and Xiangping Kong 1 , *
Authors Information
1 Liver Disease Key Lab, 458 Hospital of PLA, Guangzhou, China
Article information
  • Hepatitis Monthly: February 2016, 16 (2); e58764
  • Published Online: February 27, 2016
  • Article Type: Research Article
  • Received: November 12, 2015
  • Revised: January 6, 2016
  • Accepted: January 15, 2016
  • DOI: 10.5812/hepatmon.34420

To Cite: Li X, Liu G, Chen M, Yang Y, Xie Y, et al. A Novel Hydrodynamic Injection Mouse Model of HBV Genotype C for the Study of HBV Biology and the Anti-Viral Activity of Lamivudine, Hepat Mon. 2016 ; 16(2):e58764. doi: 10.5812/hepatmon.34420.

Abstract
Copyright © 2016, Kowsar Corp.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Scaglione SJ, Lok AS. Effectiveness of hepatitis B treatment in clinical practice. Gastroenterology. 2012; 142(6): 1360-1368 e1[DOI][PubMed]
  • 2. Liu CJ, Kao JH. Global perspective on the natural history of chronic hepatitis B: role of hepatitis B virus genotypes A to J. Semin Liver Dis. 2013; 33(2): 97-102[DOI][PubMed]
  • 3. Malmstrom S, Eilard A, Larsson SB, Hannoun C, Norkrans G, Lindh M. Genotype impact on long-term virological outcome of chronic hepatitis B virus infection. J Clin Virol. 2012; 54(4): 321-6[DOI][PubMed]
  • 4. Cui Y, Jia J. Update on epidemiology of hepatitis B and C in China. J Gastroenterol Hepatol. 2013; 28 Suppl 1: 7-10[DOI][PubMed]
  • 5. Kosaka K, Hiraga N, Imamura M, Yoshimi S, Murakami E, Nakahara T, et al. A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections. Biochem Biophys Res Commun. 2013; 441(1): 230-5[DOI][PubMed]
  • 6. Roggendorf M, Yang D, Lu M. The woodchuck: a model for therapeutic vaccination against hepadnaviral infection. Pathol Biol (Paris). 2010; 58(4): 308-14[DOI][PubMed]
  • 7. Dandri M, Lutgehetmann M. Mouse models of hepatitis B and delta virus infection. J Immunol Methods. 2014; 410: 39-49[DOI][PubMed]
  • 8. Dandri M, Lutgehetmann M, Petersen J. Experimental models and therapeutic approaches for HBV. Semin Immunopathol. 2013; 35(1): 7-21[DOI][PubMed]
  • 9. Chayama K, Hayes CN, Hiraga N, Abe H, Tsuge M, Imamura M. Animal model for study of human hepatitis viruses. J Gastroenterol Hepatol. 2011; 26(1): 13-8[DOI][PubMed]
  • 10. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, et al. Direct gene transfer into mouse muscle in vivo. Science. 1990; 247(4949 Pt 1): 1465-8[PubMed]
  • 11. Herweijer H, Wolff JA. Gene therapy progress and prospects: hydrodynamic gene delivery. Gene Ther. 2007; 14(2): 99-107[DOI][PubMed]
  • 12. Chuai X, Wang W, Chen H, Deng Y, Wen B, Tan W. Lentiviral backbone-based hepatitis B virus replicon-mediated transfer favours the establishment of persistent hepatitis B virus infection in mice after hydrodynamic injection. Antiviral Res. 2014; 101: 68-74[DOI][PubMed]
  • 13. Shashidharamurthy R, Machiah D, Bozeman EN, Srivatsan S, Patel J, Cho A, et al. Hydrodynamic delivery of plasmid DNA encoding human FcgammaR-Ig dimers blocks immune-complex mediated inflammation in mice. Gene Ther. 2012; 19(9): 877-85[DOI][PubMed]
  • 14. Suda T, Kamimura K, Kubota T, Tamura Y, Igarashi M, Kawai H, et al. Progress toward liver-based gene therapy. Hepatol Res. 2009; 39(4): 325-40[DOI][PubMed]
  • 15. Zhang G, Song YK, Liu D. Long-term expression of human alpha1-antitrypsin gene in mouse liver achieved by intravenous administration of plasmid DNA using a hydrodynamics-based procedure. Gene Ther. 2000; 7(15): 1344-9[DOI][PubMed]
  • 16. Chen ZY, Yant SR, He CY, Meuse L, Shen S, Kay MA. Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver. Mol Ther. 2001; 3(3): 403-10[DOI][PubMed]
  • 17. Ketzinel-Gilad M, Zauberman A, Nussbaum O, Shoshany Y, Ben-Moshe O, Pappo O, et al. The use of the hydrodynamic HBV animal model to study HBV biology and anti-viral therapy. Hepatol Res. 2006; 34(4): 228-37[DOI][PubMed]
  • 18. Yang D, Liu L, Zhu D, Peng H, Su L, Fu YX, et al. A mouse model for HBV immunotolerance and immunotherapy. Cell Mol Immunol. 2014; 11(1): 71-8[DOI][PubMed]
  • 19. Tzeng HT, Tsai HF, Chyuan IT, Liao HJ, Chen CJ, Chen PJ, et al. Tumor necrosis factor-alpha induced by hepatitis B virus core mediating the immune response for hepatitis B viral clearance in mice model. PLoS One. 2014; 9(7)[DOI][PubMed]
  • 20. Huang LR, Wu HL, Chen PJ, Chen DS. An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection. Proc Natl Acad Sci U S A. 2006; 103(47): 17862-7[DOI][PubMed]
  • 21. Li L, Shen H, Li A, Zhang Z, Wang B, Wang J, et al. Inhibition of hepatitis B virus (HBV) gene expression and replication by HBx gene silencing in a hydrodynamic injection mouse model with a new clone of HBV genotype B. Virol J. 2013; 10: 214[DOI][PubMed]
  • 22. Division of Research Resources. Guide for the care and use of laboratory animals 1985;
  • 23. Sunbul M. Hepatitis B virus genotypes: global distribution and clinical importance. World J Gastroenterol. 2014; 20(18): 5427-34[DOI][PubMed]
  • 24. Xibing G, Xiaojuan Y, Juanhua W, Zhong H. Relationship between HBV genotypes B, C and follicular helper T cells in patients with chronic hepatitis B and its significance. Hepat Mon. 2013; 13(1)[DOI][PubMed]
  • 25. Dion S, Bourgine M, Godon O, Levillayer F, Michel ML. Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules. J Virol. 2013; 87(10): 5554-63[DOI][PubMed]
  • 26. Dang SS, Jia XL, Song P, Cheng YA, Zhang X, Sun MZ, et al. Inhibitory effect of emodin and Astragalus polysaccharide on the replication of HBV. World J Gastroenterol. 2009; 15(45): 5669-73[PubMed]
  • 27. He Q, Tang Q, Le X, Lv D, Zhang X, Ao F, et al. The relationship between intrahepatic distribution of hepatitis B virus core antigen and serum ALT, HBV DNA levels and HBeAg Status. Infect Int (Electro Edit). 2012; 1: 84-90
  • 28. Chu CM, Shyu WC, Liaw YF. Immunopathology on hepatocyte expression of HBV surface, core, and x antigens in chronic hepatitis B: clinical and virological correlation. Dig Dis Sci. 2010; 55(2): 446-51[DOI][PubMed]
  • 29. Nguyen T, Thompson AJ, Bowden S, Croagh C, Bell S, Desmond PV, et al. Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia. J Hepatol. 2010; 52(4): 508-13[DOI][PubMed]
  • 30. Wang J, Wang B, Huang S, Song Z, Wu J, Zhang E, et al. Immunosuppressive drugs modulate the replication of hepatitis B virus (HBV) in a hydrodynamic injection mouse model. PLoS One. 2014; 9(1)[DOI][PubMed]
  • 31. Chao DC, Hu KQ. Update on rescue therapies in patients with lamivudine-resistant chronic hepatitis B. Drug Des Devel Ther. 2013; 7: 777-88[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments